Target intelligence / Profile preview

Pleckstrin homology domain containing, family O member 1 (PLEKHO1)

Target
PLEKHO1
Molecular classification
Adapter protein, Scaffold protein, Cytoskeletal regulator, Signaling modulator
01

Overview

PLEKHO1 encodes a scaffolding protein with a pleckstrin homology domain that mediates protein-protein interactions, subcellular localization, and key signaling events[1][4]. It recruits protein kinase CK2 to the plasma membrane, modulates transcription (AP-1/c-Jun), and influences apoptosis via caspase-mediated cleavage and nuclear translocation[1]. PLEKHO1 is also essential for bone formation, immune cell polarization, and the regulation of cell cycle and protein degradation. In various cancers, PLEKHO1 is dysregulated and contributes to tumorigenesis, with its roles being highly context-dependent (can be tumor suppressive or promotive depending on cancer type); genetic variants are linked to metabolic and cardiovascular risk[2][4].

Other names
CKIP-1OC120CKIP1JBPpleckstrin homology domain containing O1
02

Mechanism of action

Inhibition of PLEKHO1 (e.g., siRNA) leads to increased bone formation via suppression of Smad-dependent BMP signaling. Knockdown impairs cell viability by inhibiting Hippo and JNK signal transduction pathways (in cancer models). Regulation of AP-1/c-Jun, PI3K/Akt pathway, and protein degradation via proteasome.

03

Biological functions

Cell proliferationCell apoptosisCell differentiationCell morphology regulationMacrophage polarizationProtein ubiquitination and degradationBone formation (osteoblast function)Signal transduction
04

Disease associations

Cancer (renal cell carcinoma, glioma, oral squamous cell carcinoma)Metabolic disorders (type 2 diabetes, fatty liver disease)Cardiovascular disease (hypertension, cardiac hypertrophy)PeriodontitisOsteoporosis
05

Safety considerations

Potential context-dependent effects in cancer (PLEKHO1 may act as tumor suppressor or promoter depending on tissue type)Safety of targeting in humans is unproven
06

Interacting drugs

liposome-delivered PLEKHO1 siRNA
07

Biomarkers

PLEKHO1 expression and cleavage (candidate biomarker for some cancers, bone disorders, and metabolic conditions, but not clinically validated)

Beyond the preview

Go deeper on Pleckstrin homology domain containing, family O member 1 (PLEKHO1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pleckstrin homology domain containing, family O member 1 (PLEKHO1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call